Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
24.09. | Clinical Trial Packaging Services in Contract Manufacturing for the Pharmaceutical Industry | ||
24.09. | Pharmaceutical Wastewater Treatment and Water Purification for the Pharmaceutical Industry | ||
24.09. | Pharmaceutical Packaging Companies in Contract Manufacturing for the Pharmaceutical Industry | ||
24.09. | FDA approves UCB's BIMZELX for multiple inflammatory conditions | ||
24.09. | EC authorises LEO Pharma Anzupgo cream for chronic hand eczema | ||
23.09. | Sanofi gains exclusivity rights to Ventyx's CNS-penetrant drug in $27m deal | ||
23.09. | Pancreatic cancer: The clinical trial landscape and progress for 2024 | ||
23.09. | Pharmaceutical Compliance Management Software for the Pharmaceutical Industry | ||
23.09. | Pharmaceutical Logistics Companies and Supply Chain Specialists for the Pharmaceutical Industry | ||
23.09. | Ipsen's Iqirvo wins European approval for primary biliary cholangitis | ||
23.09. | Pharmaceutical Automation and Equipment for the Pharmaceutical Industry | ||
23.09. | Teva touts safety profile of once monthly schizophrenia therapy | ||
23.09. | Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I | ||
23.09. | Pharmaceutical Wholesalers for the Pharmaceutical Industry | ||
23.09. | Cold Chain Storage and Distribution for the Pharmaceutical Industry | ||
23.09. | EMA CHMP recommends MSD's KEYTRUDA for gynaecological cancers | ||
23.09. | MHRA approves Takeda's fruquintinib for metastatic colorectal cancer | ||
23.09. | Leading Artificial Intelligence (AI) Companies in Pharma | ||
23.09. | Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry | ||
23.09. | FDA approves AstraZeneca FluMist 'flu vaccine for self-administration | ||
23.09. | FDA approves Zevra Therapeutics' Miplyffa for Niemann-Pick disease | ||
20.09. | AI boom set to revolutionise healthcare in Europe | ||
20.09. | GC Therapeutics secures $65m to launch into off-the-shelf iPSC therapy space | ||
20.09. | Sanofi eyes approval after MS therapy slows disease progression by 31% | ||
20.09. | EMA approves Bavarian Nordic's mpox vaccine for teenagers |